Medvok Pharmaceuticals Private Limited

Medvok Pharmaceuticals Private Limited - trading in Saroop Nagar, Delhi, India. FY 2026 financials & compliance.
CIN U33309DL2017PTC313307 Incorporated 22 February 2017 ROC Delhi HQ Saroop Nagar, Delhi, India
Active Private Limited Company trading
Data last updated
Revenue · FY 2024
₹15.14 Lakh
▲ 58% YoY
Net loss · FY 2024
₹739
Net margin 0%
EBITDA · FY 2024
-₹739
EBITDA margin 0%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Medvok Pharmaceuticals Private Limited

Data last updated:

Medvok Pharmaceuticals Private Limited is a private limited company based in Saroop Nagar, Delhi, India. It operates in the retail trading segment of the trading and commerce sector. It was incorporated on 22 February 2017 and has been in existence for over 9 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33309DL2017PTC313307. Its GSTIN is 07AAKCM8467C1Z7 (Delhi).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Pawan Kumar and Jay Shankar Sahu.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kh.No.14/22 Ground Floor Rajiv Road Gali N.7 Blk E, Saroop Nagar, Delhi, India – 110042.

As per the financials filed for FY 2024, the company reported a revenue of ₹15.14 Lakh, a growth of 58% compared to the previous year. For the same year it recorded a net loss of ₹739 (net margin 0%) and EBITDA of -₹739 (EBITDA margin 0%). Revenue has grown at a compounded annual rate (CAGR) of 32% over three years and 25% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Medvok Pharmaceuticals Private Limited
CIN U33309DL2017PTC313307
Registration Number 313307
Incorporation Date 22 February 2017
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Kh.No.14/22 Ground Floor Rajiv Road Gali N.7 Blk E, Saroop Nagar, Delhi, India – 110042
  • Industry
    Trading, Retail Trading, Retailers
Comprehensive company report
Medvok Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Medvok Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Medvok Pharmaceuticals Private Limited in one report.

Financials from FY 2017 Directors & ownership Charges & compliance

Business Activity of Medvok Pharmaceuticals Private Limited

The main business activity of Medvok Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GWholesale and retail trade; repair of motor vehicles and motorcycles47Retail trade, except of motor vehicles and motorcyclesLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Medvok Pharmaceuticals Private Limited FY 2025 filings available

Medvok Pharmaceuticals Private Limited reported revenue of ₹15.14 Lakh (up 58% YoY) for FY 2024.

Revenue · FY 2024
₹15.14 Lakh ▲ 58%
Net loss · FY 2024
₹739 margin 0%
EBITDA · FY 2024
-₹739 margin 0%

Compounded Annual Growth Rate (CAGR) of Medvok Pharmaceuticals Private Limited

Revenue CAGR growth
1 year
▲ 58%
3 years · compounded
▲ 32%
5 years · compounded
▲ 25%
EBITDA CAGR growth
1 year
▼ 572%
3 years · compounded
▼ 188%
5 years · compounded
▲ 1%

Revenue has grown at a compounded annual rate (CAGR) of 25% over five years, including 58% growth in the latest year. EBITDA fell 572% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Medvok Pharmaceuticals Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA-₹739••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)-₹739••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Medvok Pharmaceuticals Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin0%••••••••••••••••
Net Profit Margin0%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Medvok Pharmaceuticals are in the company report.

Premium access

Financial statements from FY 2017

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Medvok Pharmaceuticals Private Limited

Medvok Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Attentiva Pharmaceuticals Private Limited₹15.25 Lakh (FY 2025)••••••••-30.0%••••Ranchi, Jharkhand, India
Rosalia Pharmaceuticals Private Limited₹15.24 Lakh (FY 2025)••••••••2.0%••••Gorakhpur, Uttar Pradesh, India
Panorama Pharmaceuticals Private Limited₹15.24 Lakh (FY 2024)••••••••-41.0%••••Hyderabad, Telangana, India
Ujiri Pharmaceuticals Private Limited₹15.21 Lakh (FY 2025)••••••••-17.0%••••Faridabad, Haryana, India
Vetluvin Pharmaceuticals Private Limited₹15.16 Lakh (FY 2022)••••••••145.0%••••Faizabad, Uttar Pradesh, India
Medvok Pharmaceuticals Private Limited this company₹15.14 Lakh (FY 2024)••••••••58.0%••••Saroop Nagar, Delhi, India
Bluefinch Pharmaceuticals Private Limited₹15.09 Lakh (FY 2025)••••••••-3.0%••••Kolkata, West Bengal, India
Moon Rock Pharmaceuticals Private Limited₹15.08 Lakh (FY 2025)••••••••21.0%••••Jind, Haryana, India
Synthecis Pharmaceuticals Private Limited₹15.07 Lakh (FY 2025)••••••••854.0%••••Hyderabad, Telangana, India
Awesome Pharmaceuticals Private Limited₹15.06 Lakh (FY 2025)••••••••-71.0%••••Lucknow, Uttar Pradesh, India
Kalysta Pharmaceuticals Private Limited₹15.06 Lakh (FY 2018)••••••••••••Mumbai, Maharashtra, India

Peers are the five companies nearest above and the five nearest below Medvok Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Medvok Pharmaceuticals Private Limited

Medvok Pharmaceuticals Private Limited is audited by RAJEEV SHUKLA & ASSOCIATES for the financial year 2017.

NameStatusAppointment DateCessation Date
RAJEEV SHUKLA & ASSOCIATESLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Medvok Pharmaceuticals Private Limited

Medvok Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Pawan KumarDirector22 Feb 20179 Years 7 MonthsCurrent
Jay Shankar SahuDirector22 Feb 20179 Years 7 MonthsCurrent

Ownership and Shareholding of Medvok Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Medvok Pharmaceuticals Private Limited

Medvok Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Medvok Pharmaceuticals Private Limited

Employment history and EPFO contributions of people linked to Medvok Pharmaceuticals.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Medvok Pharmaceuticals Private Limited

Medvok Pharmaceuticals Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Jay Shankar Sahu was appointed as Director on 22 Feb 2017.

AGM
Medvok Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Medvok Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Appointed
Jay Shankar Sahu was appointed as Director.
Appointed
Pawan Kumar was appointed as Director.
Incorporation
22 Feb 2017
Medvok Pharmaceuticals Private Limited was registered on 22 Feb 2017 with Roc Delhi Ii & aged 9 years 7 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Medvok Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Medvok Pharmaceuticals Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Medvok Pharmaceuticals Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Medvok Pharmaceuticals Private Limited

Medvok Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
07AAKCM8467C1Z7DelhiActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Medvok Pharmaceuticals Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Medvok Pharmaceuticals Private Limited

Medvok Pharmaceuticals is an active private limited company based in Saroop Nagar, Delhi, India. The company works in retail trading, within the trading industry. It was incorporated on 22 February 2017 (9+ years old) and is registered under CIN U33309DL2017PTC313307.

Medvok Pharmaceuticals reported revenue of ₹15.14 Lakh for FY 2024 (up 58% YoY).

Medvok Pharmaceuticals has 2 current directors:

Medvok Pharmaceuticals reported a net loss of ₹739 (net margin 0%) and EBITDA of -₹739 (EBITDA margin 0%) for FY 2024, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Medvok Pharmaceuticals is 32% over three years and 25% over five years. In the latest year (FY 2024) revenue rose 58%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Medvok Pharmaceuticals is 07AAKCM8467C1Z7, registered in Delhi.

The CIN (Corporate Identification Number) of Medvok Pharmaceuticals is U33309DL2017PTC313307. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Medvok Pharmaceuticals was incorporated on 22 February 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Medvok Pharmaceuticals by revenue are Attentiva Pharmaceuticals Private Limited, Rosalia Pharmaceuticals Private Limited, Panorama Pharmaceuticals Private Limited, Ujiri Pharmaceuticals Private Limited, Vetluvin Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).

Jay Shankar Sahu was appointed as Director on 22 Feb 2017. Pawan Kumar was appointed as Director on 22 Feb 2017.

The registered office of Medvok Pharmaceuticals is at Kh.No.1422 Ground Floor Rajiv Road Gali N.7 Blk E, Saroop Nagar, Delhi, India – 110042.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available